Health

Global market access strategy

Our strategic services help clients to navigate uncertainties and maximize value throughout the product lifecycle.

We enable market access through provision of insights that inform development of optimal payer evidence, pricing, and access strategies, while also providing solutions that help communicate value, execute on the strategy, and set our clients' assets up for commercial success. Our tailored approach aims to provide market access insights and solutions across all stages of the product lifecycle.

Connecting global value and access strategies to local health system needs and priorities

At LCP Health, we recognize that securing access and reimbursement for novel therapies requires a strategic approach tailored to each product and market. Our dedicated market access team goes beyond traditional consulting models to deliver an integrated, customized service aligned with your specific needs for value demonstration, pricing strategy, and payer engagement.

We foster early payer involvement through our global payer network for value demonstration, access, and pricing — enabling successful launches. Using real-world evidence, we quantify the full range of tangible and intangible value elements your product delivers to payers and health systems. We also bring deep experience in co-developing innovative, outcomes-based agreements that respond to evolving healthcare priorities.

With real-world health analytics at the core of our market access approach, we stand apart from typical market access consultancies by connecting global value strategies with local health system priorities. Our goal is to help you achieve broad, rapid, and sustainable patient access.

We support our clients across the following areas:

Global market access consulting

Pricing, reimbursement, and competitor landscape assessment
Payer research/advisory boards
Market access strategy/roadmap
Portfolio planning including indication sequencing and country prioritization
Business development/licensing evaluation i.e. opportunity assessment/asset due diligence

Payer value communications

Value story/messaging
Global value dossier strategy and development, including the Academy of Managed Care Pharmacy (AMCP) and formulary communications
Payer value decks and access toolkits
Objection handling
Payer simulation workshops
Internal training and preparedness
Payer-focused publications

Payer evidence generation strategy

Evidence gap analysis
Data source landscaping
Assessment of payer acceptability
Payer rationalized clinical trial design
Development of cross-functional, real-world evidence strategy across the lifecycle

Our global market access strategy team work closely with our US access solutions team who cover US focused pricing and reimbursement, patient services and trade and channel services.